Menopause Treatment Market Players Review 2023 | Fast Forward Research
Menopause causes
uncomfortable symptoms, such as hot flashes, vaginal dryness, and weight gain
and menopause treatments such as hormonal and non-hormonal treatments help to
relieve these symptoms. Over the years, major market players in the
menopause treatment are focusing on various growth strategies such as product
launches, product advancements and expansions to cater to the growing needs for
patients seeking treatment for menopause symptoms.
Global Menopause Treatment Market is expected to have a market
value of USD 17.3 Billion by 2032 at 6.10% CAGR during the forecast
period.
For instance, in
April 2019, Otsuka Pharmaceutical launched EQUELLE, a non-prescription,
non-hormonal supplement to alleviate the frequency of hot flashes and muscle
aches associated with menopause in the US. Such strategies push the demand for
branded as well as generic menopausal drugs, thus promising huge growth for the
industry.
Major Key
Players:
MRFR recognizes the following companies as the
Menopause Treatment Market Players are — Novo Nordisk A/S
(Denmark), Pfizer Inc. (US), Allergan (Ireland), Eli Lily and Company (US),
Emcure Pharmaceuticals Ltd (India), Novartis AG (Switzerland), Cipla
Inc. (India), Teva Pharmaceuticals (Israel), Merck & Co., Inc.
(US), Abbott Laboratories (US).
Segment Analysis
The global menopause treatment market is segmented based on
treatment and distribution channel.
The global menopause treatment market based on the treatment
has been segmented into hormonal treatment and non-hormonal treatment. The
hormonal treatment segment is further segmented into estrogen, progesterone,
and combination. The non-hormonal treatment is further segmented into
anti-depressants and others.
Based on distribution channel, the menopause treatment market
is segmented into hospital
pharmacies, retail pharmacies, and online stores.
Regional
Analysis
The global menopause market, based on region, has been divided into the Americas,
Europe, Asia-Pacific, and Middle East & Africa.
The Americas has been segmented
into North America and Latin America, with the North America market further
divided into the US and Canada. The Americas led the market and accounted for
the largest share in 2019 owing to the increasing product approvals and high
uptake of new technology. For instance, in July 2017, AMAG
Pharmaceuticals, Inc. (US) launched Intrarosa (prasterone) for the treatment of
moderate to severe dyspareunia a symptom of vulvar and vaginal atrophy (VVA),
due to menopause. Thus, such strategies employed by major players aid in the
increased growth rate for the Americas menopause treatment industry.
The European menopause treatment
market has been further segmented into Western Europe and Eastern Europe. The
Western Europe menopause treatment market has further been classified into
Germany, France, the UK, Italy, Spain, and the rest of Western Europe. Europe
follows the Americas in the global menopause treatment market. The increasing
inclination of companies towards female technology (femtech) is boosting the
growth of the menopause treatment market in European countries. Many digital health start-ups have identified this opportunity and are offering B2C digital
health tools, such as mobile apps, to guide menopausal women through this phase
with lifestyle intervention tips and online telehealth consultations. As a
result, the region is expected to show significant growth in the menopause
treatment market.
The menopause treatment market in
Asia-Pacific has been segmented into China, India, Japan, South Korea,
Australia, and the rest of Asia-Pacific. Asia-Pacific is expected to register
the highest growth rate over the forecast period from 2020 to 2032. This is
owing to the growing penetration of the women’s health sector, increasing
awareness about the betterment of the women’s health, and the growing number of
educational campaigns related to the benefits of hormone replacement therapy in
China, Japan, India, and Australia.
The Middle East &
Africa menopause treatment market is segmented Saudi Arabia, the
United Arab Emirates (UAE), Oman, Kuwait, Qatar, and the rest of the Middle
East & Africa. The negative connotation of menopause has resulted in a
negative attitude towards menopause in premenopausal women. However, with the
increasing awareness created by private companies, the scenario is expected to
change in the next ten years.
About Market Research Future
At Market Research Future (MRFR), we enable our
customers to unravel the complexity of various industries through our Cooked
Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research
Reports (3R), Continuous-Feed Research (CFR), and Market Research &
Consulting Services.
MRFR team have supreme objective to provide the
optimum quality market research and intelligence services to our clients. Our
market research studies by products, services, technologies, applications, end
users, and market players for global, regional, and country level market
segments, enable our clients to see more, know more, and do more, which help to
answer all their most important questions.
In order to stay updated with technology and work
process of the industry, MRFR often plans & conducts meet with the industry
experts and industrial visits for its research analyst members.
Contact us:
Market Research Future
(part of Wantstats Research and Media Private Limited),
99 Hudson Street, 5Th Floor,
New York, New York 10013
United States of America
+1 646 845 9312
Comments
Post a Comment